SINGULAIR MSD 275 (Singulair 5 mg)
Generic Name: montelukast
Pill imprint SINGULAIR MSD 275 has been identified as Singulair 5 mg.
Singulair is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Singulair 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- montelukast
- Imprint:
- SINGULAIR MSD 275
- Strength:
- 5 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Merck Sharp & Dohme Corp.
- National Drug Code (NDC):
- 00006-9275
- Inactive Ingredients:
- mannitol
microcrystalline cellulose
hydroxypropyl cellulose (type h)
ferric oxide red
croscarmellose sodium
aspartame
magnesium stearate
More about Singulair (montelukast)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
